Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01260142 · ClinicalTrials.gov registry record · Phase 4
A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion
A Phase 4 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT01260142 is a Phase 4 study that has completed, run by Eisai. The registered enrollment target is 36 participants.
The verdict
NCT01260142, a Phase 4 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is designed to characterize the pharmacokinetic and pharmacodynamic effect of fospropofol disodium in comparison to propofol. In addition, the study will compare the maximum sedative effect, safety and tolerability of fospropofol disodium and propofol.
Interventions
- DRUG Fospropofol disodium, propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01260142
The ClinicalTrials.gov registry entry for NCT01260142 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fospropofol disodium, propofol is the first listed.
NCT01260142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01260142 about?
NCT01260142 is a clinical study titled "A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion". This study is designed to characterize the pharmacokinetic and pharmacodynamic effect of fospropofol disodium in comparison to propofol. In addition, the study will compare the maximum sedative effect, safety and tolerability of fospropofol disodium and propofol.
What is the current status of trial NCT01260142?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2010-11. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01260142?
The interventions under investigation include: Fospropofol disodium, propofol (DRUG).
Who is sponsoring clinical trial NCT01260142?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.